The Food and Drug Administration says it will hold three meetings in June to discuss vaccines for young children. It’s been nearly a year and a half since the first adult doses of COVID-19 vaccines were administered, yet vaccines are still not approved for children five and under.
The FDA said Friday it plans to convene its outside panel of vaccine experts on June 8, 21 and 22 to review applications from Moderna and Pfizer for vaccines in tots and babies. The dates are tentative and regulators said they will provide more details later.
Moderna requests emergency use authorization from the FDA for its vaccine for children as young as six-months-old.
Consumer News: Reports of people getting sick after eating Lucky Charms, ways to save on your vacation and more
The U.S. Food and Drug Administration is investigating Lucky Charms cereal after dozens of consumers complained of illness after eating it.
Health care providers hoping to get new guidance on coronavirus vaccines from the FDA will have to keep waiting. Wednesday’s meeting ended with no solid answers regarding the future of booster shots and regular vaccines.
U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
On the vaccine front, an official with the FDA is suggesting a fourth dose of the COVID-19 vaccine might be needed closer to fall.
The FDA is postponing its review of Pfizer’s COVID-19 vaccine for kids under 5-years-old, citing the large number of omicron cases. On the other hand, COVID-19 restrictions are being dropped by some cities, and even retail giants.
Nearly two years after the first reported case of the coronavirus in the country, the federal government is preparing to release millions of vaccine doses to kids 6 months to 5-years-old if the FDA and CDC approve. This comes as new COVID-19 cases plunge nationwide, and a growing number of states ease restrictions.
